PALATIN TECHNOLOGIES, INC. Operating Lease, Liability, Current
PALATIN TECHNOLOGIES, INC. (PTN) had Operating Lease, Liability, Current of $189.21 thousand as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-05-13
- 2026-03-31: Operating Lease, Liability, Current $189.21K.
- 2025-12-31: Operating Lease, Liability, Current $219.73K.
- 2025-09-30: Operating Lease, Liability, Current $132.45K.
- 2025-06-30: Operating Lease, Liability, Current $129.81K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-03-31 | $189.21K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $219.73K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $132.45K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $129.81K 10-Q · filed 2026-05-13 |
| 2025-03-31 | $194.97K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $257.67K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $319.52K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $380.54K 10-K · filed 2025-09-23 |
| 2024-03-31 | $371.28K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $363.72K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $326.95K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $354.05K 10-K · filed 2024-09-30 |
| 2023-03-31 | $301.17K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $335.73K 10-Q · filed 2023-02-14 |
| 2022-09-30 | $343.75K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $371.12K 10-K · filed 2023-09-28 |
| 2022-03-31 | $367.48K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $360.65K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $353.93K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $351.85K 10-K · filed 2022-09-22 |
| 2021-03-31 | $347.07K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $265.34K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $282.27K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $312.78K 10-K · filed 2021-09-28 |
| 2019-06-30 | $0.00 10-K · filed 2020-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |